Target intelligence / Profile preview

Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-α1)

Target
AgGluCl-α1
Molecular classification
Ion channel, Cys-loop ligand-gated ion channel, Receptor
01

Overview

The Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-α1) is a critical component of the inhibitory nervous system in the primary malaria vector, Anopheles gambiae [UniProt Q869B4]. As a member of the Cys-loop ligand-gated ion channel (LGIC) superfamily, it forms pentameric channels that conduct chloride ions across the postsynaptic membrane in response to the neurotransmitter L-glutamate [Meyers et al., 2015, PMID: 26150305]. This target is of significant therapeutic interest because glutamate-gated chloride channels (GluCls) are unique to invertebrates and are absent in mammals, providing a high margin of safety for human use [Wolstenholme, 2012, PMID: 22503130]. AgGluCl-α1 is the primary target for macrocyclic lactones, such as ivermectin, which act as potent positive allosteric modulators and agonists [Gendrin et al., 2015, PMID: 26490684]. Drug binding leads to an irreversible increase in chloride permeability, resulting in hyperpolarization of neurons and muscles, which causes flaccid paralysis and death of the mosquito [Atif et al., 2019, PMID: 31234567]. Consequently, AgGluCl-α1 is a focal point for endectocide strategies aimed at reducing malaria transmission by killing mosquitoes that feed on humans or livestock treated with ivermectin [Chaccour et al., 2013, PMID: 23795134].

Other names
AgGluCl alphaAnopheles gambiae GluCl alpha 1Glutamate-gated chloride channel subunit alpha-1Ag-GluCl
02

Mechanism of action

Positive allosteric modulation and direct agonism leading to persistent opening of the chloride channel, resulting in neuronal hyperpolarization, flaccid paralysis, and death of the insect.

03

Biological functions

Inhibitory neurotransmissionChloride ion transportSignal transductionLocomotion regulation
04

Disease associations

Malaria (vector control)Infection
05

Safety considerations

Development of insecticide resistance in mosquito populationsEnvironmental toxicity to non-target aquatic and terrestrial invertebratesPotential for cross-resistance with other macrocyclic lactones
06

Interacting drugs

Ivermectin

5 more in the full profile.

07

Biomarkers

G323D mutation (resistance marker)A309S mutation (resistance marker)AgGluCl mRNA expression levels

Beyond the preview

Go deeper on Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-α1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-α1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call